Skip to main content
Psychedelic State(s) of America
Live · TradingView

NEWS · COMMENTARY · ANALYSIS · EDUCATION

Psychedelic State(s) of America

Psychedelic State(s) of America is dedicated to empowering rigorously independent psychedelic news, commentary, analysis, and education across the United States and around the world — from psilocybin and ibogaine policy to MDMA therapy research.

Read the latestAbout PSA
¿Hablas español?Visita PSA en español

Latest psychedelic news

News and commentary, newest first. Page 1 of 43.

All newsAll commentary
"How Psychedelic Therapy is Used to Continue the US War Machine" - PSA's Sunday Sound-Off: October 18, 2026
Commentary29 min read

"How Psychedelic Therapy is Used to Continue the US War Machine" - PSA's Sunday Sound-Off: October 18, 2026

Plus: "Is the Liberation of Spirituality from Religion the great liberation of our time?" and the PSA NewsWire Highlights of the Week!

PSA Media Team
Hype, Hope, and Reality: Where the Movement Really Stands – LIVE in Houston Next Month with PsyT and PSA
PSA Media Partner2 min read

Hype, Hope, and Reality: Where the Movement Really Stands – LIVE in Houston Next Month with PsyT and PSA

Join PSA Founder Jack Gorsline at PsyT Houston on Saturday, November 7th for a candid look at where the psychedelic movement really stands.

PSA Newsroom
Introducing Alt(HER)ed States: Psychedelics x Women's Health
PSA Media Partner4 min read

Introducing Alt(HER)ed States: Psychedelics x Women's Health

A new project dedicated to elevating the future of psychedelics and women's health research, education, leadership, and more.

Gianna Biscontini
Proposed New Mexico Medical Psilocybin Program Regulation Changes Spark Outcry
Politics8 min read

Proposed New Mexico Medical Psilocybin Program Regulation Changes Spark Outcry

Clinicians, Advocates and Lawmakers Rebuke New Mexico Health Department Over Restrictive Draft Psilocybin Rules

Jack Gorsline
The Receipts and the Results: Louisiana's Ibogaine Trials - PSA's Regulatory Dispatch, Vol. 1
Commentary18 min read

The Receipts and the Results: Louisiana's Ibogaine Trials - PSA's Regulatory Dispatch, Vol. 1

Louisiana is funding ibogaine trials with opioid settlement money. The agreement governing that money requires someone to publish where every dollar went. The statute spending it requires nothing about what the trials find.

Odette Alina Hauke, M.S.
“If Psychedelics Can Heal, Why Wait Until We're Broken?" - The Psychedelic Silver Screen, Vol. II
PSA Media Partner1 min read

“If Psychedelics Can Heal, Why Wait Until We're Broken?" - The Psychedelic Silver Screen, Vol. II

An Interview with Psychedelic Filmmaker Xavier Rousset, Director of "A Trip to Transformation" - Produced in Partnership by Psychedelic State(s) of America and The Chronicles of Kykeon

PSA Media Partner

Commentary

Opinions and analysis from the PSA network. Page 1 of 14.

All op-eds
"How Psychedelic Therapy is Used to Continue the US War Machine" - PSA's Sunday Sound-Off: October 18, 2026
Commentary29 min read

"How Psychedelic Therapy is Used to Continue the US War Machine" - PSA's Sunday Sound-Off: October 18, 2026

Plus: "Is the Liberation of Spirituality from Religion the great liberation of our time?" and the PSA NewsWire Highlights of the Week!

PSA Media Team
The Receipts and the Results: Louisiana's Ibogaine Trials - PSA's Regulatory Dispatch, Vol. 1
Commentary18 min read

The Receipts and the Results: Louisiana's Ibogaine Trials - PSA's Regulatory Dispatch, Vol. 1

Louisiana is funding ibogaine trials with opioid settlement money. The agreement governing that money requires someone to publish where every dollar went. The statute spending it requires nothing about what the trials find.

Odette Alina Hauke, M.S.
"Considerations for the FDA on Postpartum-depression, for the record" - PSA's Sunday Sound-Off: September 20th, 2026
Commentary5 min read

"Considerations for the FDA on Postpartum-depression, for the record" - PSA's Sunday Sound-Off: September 20th, 2026

"On Postpartum-depression, for the record: Considerations for the FDA," ICYMI: "What's the most pressing issue facing psychedelics in the U.S.?" plus the PSA NewsWire Highlights of the Week

Stephanie Karzon Abrams
PSA's Sunday Sound-Off: The race to commercialize psychedelic therapy is accelerating, but at what cost?
Commentary7 min read

PSA's Sunday Sound-Off: The race to commercialize psychedelic therapy is accelerating, but at what cost?

Plus "Repeated Patterns of AI, SSRIs & GLP-1s: Considerations Critical for Sustainability, Health and Happiness," and the PSA NewsWire Highlights of the Week for September 13th, 2026

PSA Media Team
PSA Newswire banner: an animated typewriter spelling out 'Psychedelic State(s) of America'

PSA Newswire

Weekly dispatches from across the psychedelic landscape, plus the latest stories moving on the wire.

See the full PSA Newswire

PSA NewsWire Highlights of the Week

📜 Law & Policy

Marijuana Moment logoFrom our friends at Marijuana Moment

Psychedelic Church’s Secret Agreement With DEA And Approval From Iowa Officials Allows Import And Manufacturing Of Ayahuasca

By Tom Angell

💰 Business

Meanwhile, over at STAT News…

Former FDA officials blast DOGE as ‘one of the biggest disasters in American history’

By Chelsea Cirruzzo

🎨 Culture

From our friends at DoubleBlind

Indigenous Peoples’ Day Ain’t Over, and Urban Indigenous Collective Is Throwing a Party About It

By Mary Carreon

💊 Science & Research

How to Change Your Behavior

By Gianna Biscontini

Latest from the wire

Community

Upcoming psychedelic events

See the full calendar

Watch the Latest

Fresh video from the PSA YouTube channel.

Subscribe
Newsletter

Subscribe to Psychedelic State(s) of America

Subscribe TODAY to get the highest quality independent psychedelic journalism covering policy, science, culture, and more — no spam, unsubscribe anytime.

Topics you care about

Optional. Pick the beats you want flagged in your briefing.

Subscribe via RSS

Follow PSA

Independent psychedelic journalism, wherever you already spend your time.